Privacy and confidentiality of genetic information: what rules for the new science?
This review covers the ethical, legal, and policy issues associated with the generation and dissemination of genetic information. First, conceptual issues, such as the definition of terms and the description of two modes of analysis, are addressed. Research findings on public attitudes toward privacy and genetics and other factors relevant to policy making are also reviewed. Second, the example of genetic research is used to highlight the importance of attention to the intrinsic harms associated with violations of genetic privacy. Subtopics include national databases and biobanks, gene brokers, and pharmacogenomics. Third, the example of insurer access to genetic information is used to highlight the importance of attention to discrimination and other instrumental harms associated with failures of regulation. Fourth, a summary of the preceding sections leads into an outline of a program for realizing the benefits of the new science in a manner that affirms rather than erodes privacy and other important values.
Anderlik
M R
MR
Institute for Bioethics, Health Policy, and Law, University of Louisville School of Medicine, Louisville, Kentucky 40292, USA. mrande02@gwise.louisville.edu
Rothstein
M A
MA
D003219:Confidentiality; D004989:Ethics; D030661:Genetic Privacy; D005820:Genetic Testing / Q000331:legislation & jurisprudence*; D006801:Humans; D007348:Insurance, Health; D011287:Prejudice; D011639:Public Opinion; D011640:Public Policy